RMD

RESMED INC
$228.25previous close on: 9/16/2026

Company Information

Company Name
RESMED INC
CIK
CIK0000943819
Category
Large accelerated filer
Ticker: Exchange
RMD: NYSE, RSMDF: OTC
Fiscal Year End
June 30
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
RMD

SEC filing data through

Insider Sentiment

Last purchase
Last sale
2026-06-08
Shares purchased (TTM)
0
Shares sold (TTM)
122,304
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
93,858,433
Shares outstanding
145,340,000
Ownership
64.58%
+4.17% Y/Y

Earnings Market Reaction

Filing date
2026-08-13
Price on filing date
1-month reaction
1.00%
3-month reaction
Pending
Drift continued7/11 (64%)
Faded / reversed4/11 (36%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value1,4691,6611,4171,3841,209933522426238238210209
Accounts Receivable Net Current1,036999986907939908860811837779730692
Inventory Net946912922946928863882918822829933958
Assets Of Disposal Group Including Discontinued Operation457---0-------
Assets Current4,3254,0643,8193,6263,5063,2082,8362,6412,3582,3512,3782,305
Assets Noncurrent
Property Plant And Equipment Net582567564564551535520560548540552534
Operating Lease Right Of Use Asset153162166162167153151157151147153123
Goodwill2,9103,0433,0443,0443,0472,8492,8052,8862,8422,8362,8622,812
Finite Lived Intangible Assets Net453425430447465430438479486501528563
Deferred Income Taxes And Other Assets Noncurrent329313286276253217209221204162156138
Other Assets Noncurrent215211194190186175181279284277276265
Assets Noncurrent4,6414,7204,6854,6834,6694,3584,3054,5814,5154,4634,5274,436
Assets8,9668,7848,5038,3088,1747,5677,1417,2226,8726,8156,9056,741
Liabilities Current
Accounts Payable Current309273250267278223220249238177202177
Accrued Liabilities Current495446392396402386353366378356332348
Operating Lease Liability Current292930303129282825242422
Contract With Customer Liability Current163179176168166160157157153151149147
Accrued Income Taxes Current981631401351321338594108554767
Short Term Borrowings2602602602601010101010101010
Liabilities Of Disposal Group Including Discontinued Operation Current41---0-------
Liabilities Current1,3951,3511,2481,2561,019941852904911773764771
Liabilities Noncurrent
Contract With Customer Liability Noncurrent171163160159157151147144137132127121
Deferred Income Taxes And Other Tax Liabilities Noncurrent657878787879778479878988
Operating Lease Liability Noncurrent137150154148153138139144141136141112
Accrued Income Taxes Noncurrent----0---0121212
Other Liabilities Noncurrent21314613913814249118342487334
Long Term Debt3994044044096586636636686979971,2171,352
Liabilities Noncurrent9859419349321,1871,0801,0361,1231,0981,4121,6591,720
Liabilities2,3812,2922,1822,1872,2072,0211,8882,0272,0082,1852,4232,490
Stockholders Equity
Preferred Stock Value000000000000
Common Stock Value Outstanding111111111111
Additional Paid In Capital Common Stock2,1912,1342,1032,0622,0341,9901,9571,9251,8971,8481,8231,791
Retained Earnings Accumulated Deficit7,2556,9596,6476,3426,0815,7795,4925,2254,9924,7704,5404,402
Treasury Stock Common Value-2,779-2,577-2,400-2,223-2,073-1,973-1,898-1,823-1,773-1,723-1,673-1,623
Accumulated Other Comprehensive Income Loss Net Of Tax-83-25-30-61-75-251-299-132-252-265-208-320
Stockholders Equity6,5856,4926,3216,1215,9685,5465,2535,1954,8644,6304,4824,250
Liabilities And Stockholders Equity8,9668,7848,5038,3088,1747,5677,1417,2226,8726,8156,9056,741
Allowance For Doubtful Accounts Receivable Current262929252220212421202221
Preferred Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized222222222222
Preferred Stock Shares Issued000000000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized350350350350350350350350350350350350
Common Stock Shares Issued191191191190190190190190190189189189
Shares Outstanding144145146146146147147147147147147147
Treasury Stock Common Shares474645444444434343424242
Prepaid Expense And Other Assets Current416493494389429505572486460505505445

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

RESMED INC (RMD) — SEC Financial Statements & Analysis

RESMED INC (RMD) is a surgical & medical instruments & apparatus company, incorporated in DE. RESMED INC trades on NYSE, OTC as: RMD, RSMDF. RESMED INC (RMD)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), RESMED INC carries a market cap of $28.28B, a P/E ratio of 18.56x, a P/B ratio of 4.29x, a P/S ratio of 5.00x, an enterprise value of $27.47B, and an EV/EBITDA multiple of 13.16x. On profitability, it posts a gross margin of 61.06%, an operating margin of 33.37%, a net margin of 26.94%, a Return on Equity (ROE) of 24.27%, a Return on Assets (ROA) of 17.77%, and a Return on Invested Capital (ROIC) of 26.23%. Per share, it reports EPS of $10.47, diluted EPS of $10.43, free cash flow per share of $11.34, and a dividend per share of $2.40. Over the trailing year, it posted revenue growth of 9.85% year-over-year, net income growth of 8.75% year-over-year, and EPS growth of 9.64% year-over-year. On the balance sheet, it maintains a current ratio of 3.10x, a quick ratio of 2.12x, working capital of $2.93B, a debt-to-equity ratio of 0.36x, a debt ratio of 0.27, an interest coverage ratio of 37.80x, free cash flow of $1.65B (TTM), and net debt of $-809.87M. Figures sourced from SEC EDGAR.

Market Cap
$28.28B
P/E TTM
18.56x
EPS TTM
$10.47
P/B TTM
4.29x
ROE TTM
24.27%
ROA TTM
17.77%
Debt To Equity
0.36x
Free Cash Flow TTM
$1.65B
Net Revenue TTM Growth 1Y
9.85%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RESMED INC in?

RESMED INC (RMD) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does RMD trade on?

RESMED INC (RMD) trades on the NYSE, OTC.

Where is RESMED INC incorporated?

RESMED INC is incorporated in DE.

When was RESMED INC (RMD)'s most recent SEC filing?

RESMED INC (RMD)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-13.

What is RMD's market cap?

RESMED INC (RMD) has a market capitalization of $28.28B as of 2026-06-30.

What is RMD's P/E ratio?

RESMED INC (RMD)'s trailing twelve month P/E ratio is 18.56x as of 2026-06-30.

What is RMD's EPS (earnings per share)?

RESMED INC (RMD)'s trailing twelve month EPS is $10.47 as of 2026-06-30.

What is RMD's ROE (return on equity)?

RESMED INC (RMD)'s trailing twelve month Return on Equity (ROE) is 24.27% as of 2026-06-30.

What is RMD's ROA (return on assets)?

RESMED INC (RMD)'s trailing twelve month Return on Assets (ROA) is 17.77% as of 2026-06-30.

What is RMD's ROIC (return on invested capital)?

RESMED INC (RMD)'s trailing twelve month Return on Invested Capital (ROIC) is 26.23% as of 2026-06-30.

What is RMD's EV/EBITDA?

RESMED INC (RMD)'s trailing twelve month EV/EBITDA is 13.16x as of 2026-06-30.

Wall Street's data.
Main Street's price.